BREAKING: Futures Fall On Weak Microsoft Guidance
The Relative Strength (RS) Rating for Canada Goose Holdings (GOOS) headed into a new percentile Tuesday, as it got a lift from 65 to 75.
When you’re researching the best stocks to buy and watch, keep a close on eye on relative price strength.
IBD’s unique RS Rating identifies market leadership by showing how a stock’s price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains often have an RS Rating of above 80 in the early stages of their moves. See if Canada Goose Holdings stock can continue to rebound and clear that threshold.
Looking For The Best Stocks To Buy And Watch? Start Here
Canada Goose Holdings stock is building a cup without handle pattern with a 22.78 entry. See if it can break out in heavy volume. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips.
While revenue growth fell last quarter from 24% to 19%, EPS grew 69%, up from 0% in the previous report. Look for the next report on or around Feb. 9.
Canada Goose Holdings stock holds the No. 8 rank among its peers in the Apparel-Clothing Manufacturing industry group. Capri Holdings (CPRI) and Tapestry (TPR) are also among the group’s highest-rated stocks.
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
YOU MAY ALSO LIKE:
MarketSmith’s Tools Can Help The Individual Investor
IBD Live: A New Tool For Daily Stock Market Analysis
Profit From Short-Term Trends With SwingTrader
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
1/12/2023 Canada Goose Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.
1/12/2023 Canada Goose Holdings shows improving price performance, earning an upgrade…
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2023 Investor’s Business Daily, LLC. All rights reserved
